NASDAQ: MYNZMainz Biomed Nv Stock Ownership - Who owns Mainz Biomed Nv?
Insider buying vs selling
Have Mainz Biomed Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kevin Michael Donahue | 10% Owner | 2025-10-17 | 643,850 | $0.62 | $399.19kBuy |
| Kevin Michael Donahue | 10% Owner | 2025-10-17 | 643,850 | $0.62 | $399.19kBuy |
| Kevin Michael Donahue | 10% Owner | 2025-10-17 | 685,000 | $1.51 | $1.03MBuy |
MYNZ insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MYNZ insiders and whales buy or sell their stock.
MYNZ Shareholders
What type of owners hold Mainz Biomed Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 18.95% | 775,263 | $472.91k | Institution |
| Kevin Michael Donahue | 16.74% | 685,000 | $417.85k | Insider |
| Guido Baechler | 14.79% | 605,058 | $369.09k | Insider |
| William J. Caragol | 8.99% | 367,899 | $224.42k | Insider |
| Cerity Partners LLC | 3.99% | 163,253 | $99.58k | Institution |
| Heinrich 1. Dreismann | 1.58% | 64,700 | $39.47k | Insider |
| Gregory J. Tibbitts | 1.37% | 55,875 | $34.08k | Insider |
| Ubs Group Ag | 1.32% | 54,181 | $33.05k | Institution |
| Hans Hekland | 1.10% | 45,000 | $27.45k | Insider |
| Steward Partners Investment Advisory LLC | 0.73% | 30,000 | $18.30k | Institution |
MYNZ vs Diagnostic & Research Stocks
Mainz Biomed Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.